
Ry Leahy
@RySciComms
Followers
823
Following
12K
Media
296
Statuses
3K
Science Communications for Advanced Therapies - Cell & Gene Therapy - Rare Patient (EoE) @phacilitate / #cellltherapy #genetherapy #firstgenacademic
Oxford, UK
Joined May 2022
Added to the @Phacilitate Library - @SuleikaJaouad ✨
Watched American Symphony last night; was told that it was a doc about @JonBatiste’s journey to the Grammys. Did not realise it would be primarily @SuleikaJaouad’s brave and candid journey through treatment for AML. Thanks for the bait-and-switch @AbbeyGPalmer….
0
0
0
RT @BLLPHD: Cellular gene therapy access in Africa: a multifactorial feasibility analysis for implementation @Cytotherapy .
0
1
0
RT @theAliceRoberts: You only have to go back a couple of hundred years and parents - reasonably and realistically - expected half their ch….
0
1K
0
RT @BLLPHD: Wharton EMBA Team Drives Cancer Innovation in Africa -in which EMBA students designed a roadmap for implementation of advanced….
wharton.upenn.edu
When Prof. Stephen Sammut, WG’84, asked his Healthcare Entrepreneurship students whether Chimeric Antigen Receptor T-cell therapy (CAR-T) cancer therapy could be brought to the African continent, he...
0
1
0
RT @BLLPHD: Deadly failure- Evidence-based medicine competes, often unsuccessfully, with charismatic influencers and slick TikTok videos. B….
0
4
0
RT @matthewherper: Event alert!. Free tickets to attend STAT's event at the Broad Institute on innovations in women's health are almost gon….
0
6
0
RT @BLLPHD: Checking all the boxes.1) "Post hoc candor" - belated pretend honesty .2) "Credibility Backfill" - The strategic rebranding of….
0
1
0
A must see for patient advocates - the unconditional love, the pain, the mental health (of patients and loved ones) and also the bright spark of having brilliant healthcare professionals to support your journey
netflix.com
In this deeply moving documentary, musician Jon Batiste attempts to compose a symphony as his wife, writer Suleika Jaouad, undergoes cancer treatment.
0
0
0
Watched American Symphony last night; was told that it was a doc about @JonBatiste’s journey to the Grammys. Did not realise it would be primarily @SuleikaJaouad’s brave and candid journey through treatment for AML. Thanks for the bait-and-switch @AbbeyGPalmer….
1
0
0
Advanced therapies Europe already has more therapeutic developer attendees registered than attended last year. Hyper excited for Barcelona! . #ATE25.
0
0
5
RT @CIRMnews: CIRM’s DISC5 funding program supports innovative, exploratory research in #StemCell biology and #RegenerativeMedicine, focusi….
0
3
0
RT @biocat_bioregio: 🔍 3 keys to Catalonia’s leadership in advanced therapies. Noelia Mateo, Global Director of Advanced Therapies, Busine….
0
1
0
Bit star struck by our panel today - looking forward to it!.
Today’s webinar: What is needed to progress ATMPs in Europe?. - Miguel Forte, @ISCTglobal / Kiki Tx.- Lindsay Davies, @NextCellPharma .- Bo Wiinberg, @novonordiskfond Cellerator.- @montsedabanm, @biocat_bioregio .- @RySciComms, @Phacilitate .
0
0
0
RT @biocat_bioregio: 🔬 What's next for ATMPs in Europe? Join Montse Daban + experts for a webinar with @Phacilitate!. Thu, July 10, 1:30 PM….
0
1
0
Today’s webinar: What is needed to progress ATMPs in Europe?. - Miguel Forte, @ISCTglobal / Kiki Tx.- Lindsay Davies, @NextCellPharma .- Bo Wiinberg, @novonordiskfond Cellerator.- @montsedabanm, @biocat_bioregio .- @RySciComms, @Phacilitate .
bigmarker.com
Ahead of Phacilitate’s Advanced Therapies Europe, Join key industry experts to discuss the current state and trajectory of ATMPs in the EU. As the world has seen seismic shifts in the funding,...
0
0
4
Terrible idea from the government that would strip funding from healthcare institutions that need it most
theguardian.com
Health leaders say financial penalties are not the answer, warning NHS faces existential threat unless it reconnects with public
0
0
0
RT @BLLPHD: 🚨🚨🚨Big news for development of in vivo CAR T cells: AbbVie (ABBV) to Acquire Capstan Therapeutics for $2.1 Billion @abbvie @cap….
streetinsider.com
AbbVie (NYSE: ABBV) and Capstan Therapeutics, Inc. ("Capstan"), a clinical-stage biotechnology company dedicated to advancing in vivo engineering of cells through RNA delivery using tLNPs, today...
0
20
0